Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 3/2019

Open Access 01-06-2019 | Case Report

Primary gastrointestinal amyloidosis with gastrointestinal hemorrhage and intestinal pseudo-obstruction: a report of a rare case

Authors: Yasutoshi Shiratori, Katsuyuki Fukuda, Takashi Ikeya, Koichi Takagi, Kenji Nakamura

Published in: Clinical Journal of Gastroenterology | Issue 3/2019

Login to get access

Abstract

Amyloidosis is a syndrome involving amyloid protein deposition in various organs, resulting in organ dysfunction. Symptoms of gastrointestinal amyloidosis are usually nonspecific, such as diarrhea and body weight loss. We, here, report a patient who presented to the hospital with simultaneous hematemesis, melena, and intestinal pseudo-obstruction, leading to a diagnosis of primary gastrointestinal amyloidosis based on computed tomography (CT) and endoscopic findings. CT showed diffuse wall thickening from the duodenum to the jejunum, jejunal dilation, and fluid accumulation throughout the gastrointestinal tract. Upper gastrointestinal endoscopy revealed duodenal mucosal edema, jejunal dilation, and small hemorrhages from jejunal mucosal erosion. The definite diagnosis was done based on biopsy results. This report describes the early diagnosis of gastrointestinal amyloidosis based on CT and endoscopy findings.
Literature
1.
go back to reference Nienhuis HL, Bijzet J, Hazenberg BP. The prevalence and management of systemic amyloidosis in Western countries. Kidney Dis Basel Switz. 2016;2:10–9.CrossRef Nienhuis HL, Bijzet J, Hazenberg BP. The prevalence and management of systemic amyloidosis in Western countries. Kidney Dis Basel Switz. 2016;2:10–9.CrossRef
2.
go back to reference Cowan AJ, Skinner M, Seldin DC, et al. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica. 2013;98:141–6.CrossRefPubMedPubMedCentral Cowan AJ, Skinner M, Seldin DC, et al. Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience. Haematologica. 2013;98:141–6.CrossRefPubMedPubMedCentral
3.
go back to reference Willekens I, Vandenbroucke F, Sennesael J, et al. Gastrointestinal amyloidosis presenting as enterocolitis on abdominal CT scan. J Radiol Case Rep. 2009;3:11–4.PubMedPubMedCentral Willekens I, Vandenbroucke F, Sennesael J, et al. Gastrointestinal amyloidosis presenting as enterocolitis on abdominal CT scan. J Radiol Case Rep. 2009;3:11–4.PubMedPubMedCentral
4.
go back to reference Sattianayagam P, Gibbs S, Hawkins P, et al. Systemic AL (light-chain) amyloidosis and the gastrointestinal tract. Scand J Gastroenterol. 2009;44:1384–5.CrossRefPubMed Sattianayagam P, Gibbs S, Hawkins P, et al. Systemic AL (light-chain) amyloidosis and the gastrointestinal tract. Scand J Gastroenterol. 2009;44:1384–5.CrossRefPubMed
5.
go back to reference Basavaraju KP, Mansour D, Barnes S, et al. A rare cause of dysphagia and gastroparesis. BMJ Case Rep. 2009;2009:bcr0720080358. Basavaraju KP, Mansour D, Barnes S, et al. A rare cause of dysphagia and gastroparesis. BMJ Case Rep. 2009;2009:bcr0720080358.
6.
go back to reference Tian L, Tang A, Zhang X, et al. Incomplete ileus and hemafecia as the presenting features of multi-organ involved primary systemic AL amyloidosis: a rare case report. BMC Gastroenterol. 2017;17:72.CrossRefPubMedPubMedCentral Tian L, Tang A, Zhang X, et al. Incomplete ileus and hemafecia as the presenting features of multi-organ involved primary systemic AL amyloidosis: a rare case report. BMC Gastroenterol. 2017;17:72.CrossRefPubMedPubMedCentral
7.
go back to reference Iwahashi N, Tame E, Nagasaka T, et al. Massive hemorrhage and pseudo-obstruction of the small intestine caused by primary AL amyloidosis associated with gastric cancer: report of a case. Surg Today. 2004;34:871–4.CrossRefPubMed Iwahashi N, Tame E, Nagasaka T, et al. Massive hemorrhage and pseudo-obstruction of the small intestine caused by primary AL amyloidosis associated with gastric cancer: report of a case. Surg Today. 2004;34:871–4.CrossRefPubMed
8.
go back to reference Lau CF, Fok KO, Hui PK, et al. Intestinal obstruction and gastrointestinal bleeding due to systemic amyloidosis in a woman with occult plasma cell dyscrasia. Eur J Gastroenterol Hepatol. 1999;11:681–5.CrossRefPubMed Lau CF, Fok KO, Hui PK, et al. Intestinal obstruction and gastrointestinal bleeding due to systemic amyloidosis in a woman with occult plasma cell dyscrasia. Eur J Gastroenterol Hepatol. 1999;11:681–5.CrossRefPubMed
9.
go back to reference Leong RY, Nio K, Plumley L, et al. Systemic amyloidosis causing intestinal hemorrhage and pseudo-obstruction. J Surg Case Rep. 2014;9:rju087.CrossRef Leong RY, Nio K, Plumley L, et al. Systemic amyloidosis causing intestinal hemorrhage and pseudo-obstruction. J Surg Case Rep. 2014;9:rju087.CrossRef
10.
go back to reference Tada S, Iida M, Yao T, et al. Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein. Gastrointest Endosc. 1994;40:45–50.CrossRef Tada S, Iida M, Yao T, et al. Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein. Gastrointest Endosc. 1994;40:45–50.CrossRef
11.
go back to reference Iida T, Yamano H, Nakase H. Systemic amyloidosis with gastrointestinal involvement: diagnosis from endoscopic and histological views. J Gastroenterol Hepatol. 2018;33:583–90.CrossRefPubMed Iida T, Yamano H, Nakase H. Systemic amyloidosis with gastrointestinal involvement: diagnosis from endoscopic and histological views. J Gastroenterol Hepatol. 2018;33:583–90.CrossRefPubMed
12.
go back to reference Okuda Y, Yamada T, Ueda M, et al. First nationwide survey of 199 patients with amyloid A amyloidosis in Japan. Int Med. 2018;2018:1099–18. Okuda Y, Yamada T, Ueda M, et al. First nationwide survey of 199 patients with amyloid A amyloidosis in Japan. Int Med. 2018;2018:1099–18.
Metadata
Title
Primary gastrointestinal amyloidosis with gastrointestinal hemorrhage and intestinal pseudo-obstruction: a report of a rare case
Authors
Yasutoshi Shiratori
Katsuyuki Fukuda
Takashi Ikeya
Koichi Takagi
Kenji Nakamura
Publication date
01-06-2019
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 3/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-018-00929-9

Other articles of this Issue 3/2019

Clinical Journal of Gastroenterology 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.